In this study, we evaluated the effects of selective and liver-targeted ACC1 and/or ACC2 inhibition in a mouse model of MASH induced by chronic Amylin diet feeding. The gene discussed is IAPP; the disease is metabolic dysfunction-associated steatohepatitis.